VISCOGLIOSI BROTHERS BID TO ACQUIRE BMP ASSETS (Orthopedics This Week)
Viscogliosi Brothers, LLC, the leading merchant banker in the global orthopedics industry, has made a bid to acquire the patent estate for an innovative line of bone morphogenic proteins (BMP) which originated at Wyeth, went to Pfizer and then eventually wound up at Bioventus, a global leader in orthobiologic solutions.
On July 23, Bioventus announced that it had entered into a definitive agreement to divest its BMP intellectual property portfolio to a new company formed by Viscogliosi Brothers, LLC (VB).
Bioventus h...
